Skip to main content
. 2024 Nov 26;15:1471017. doi: 10.3389/fimmu.2024.1471017

Table 2.

Tumor treatment response assessment.

Characteristics RECIST mRECIST
Complete response (CR) 2 (3.9%) 4 (7.8%)
Partial response (PR) 21 (41.2%) 27 (52.9%)
Stable disease (SD) 22 (43.1%) 14 (27.5%)
Progressive disease (PD) 6 (11.8%) 6 (11.8%)
Objective response rate (ORR) 23 (45.1%) 31 (60.8%)
Disease control rate (DCR) 45 (88.2%) 45 (88.2%)

RECIST, Response Evaluation Criteria in Solid Tumors; mRECIST, modified RECIST.